Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diseases of the Skin and Subcutaneous Tissue”

353 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 353 results

Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Study completedNCT05780515
What this trial is testing

ANX009 in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Annexon, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT02124798
What this trial is testing

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 95
Large-scale testing (Phase 3)Active Not RecruitingNCT06548100
What this trial is testing

The Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 9
Large-scale testing (Phase 3)Enrolling By InvitationNCT07007637
What this trial is testing

Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 835
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Early research (Phase 1)Study completedNCT02306629
What this trial is testing

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma S.P.R.L. 42
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Not applicableStudy completedNCT05424926
What this trial is testing

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis
Assistance Publique - Hôpitaux de Paris 22
Large-scale testing (Phase 3)Study completedNCT02067910
What this trial is testing

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University Medical Center Groningen 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Post-approval studies (Phase 4)Ended earlyNCT01738724
What this trial is testing

Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin

Who this might be right for
Uterine Leiomyoma
University of Sao Paulo 14
Large-scale testing (Phase 3)Study completedNCT01566721
What this trial is testing

A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 2,577
Large-scale testing (Phase 3)Study completedNCT02194166
What this trial is testing

Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration

Who this might be right for
Breast Cancer
Hoffmann-La Roche 90
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Load More Results